Overview


According to FutureWise analysis the market for Dialysis Access Treatment Devices is expected to reach US$ 0.75 billion by 2031 at a CAGR of 5.50%.

Hemodialysis access, also known as vascular access, is a method of obtaining blood for hemodialysis. Blood travels through soft tubes to the dialysis machine, where it is cleaned as it passes through a specific filter known as a dialyzer. A small operation is used to create an access. When the kidneys aren't working properly, dialysis helps to maintain electrolytes and fluid balance. Various dialysis equipment are often used to eliminate waste and fluid from the body. Furthermore, the COVID-19 infection has shown evidence of impacting the kidneys, causing damage to the organ and causing acute renal infection (AKI). The rise in incidence of end-stage renal disease (ESRD) patients around the world, the rise in the prevalence of diabetes in developing countries, and the global shortage of donor kidneys are all projected to enhance the growth of the dialysis access treatment devices market over the forecast period. Furthermore, the favourable repayment scenario offered for dialysis treatment in various countries, as well as research and development in both developed and developing economies, are propelling the dialysis access treatment devices market forward. Obstacles in treatment and an increase in the price of dialysis equipment, on the other hand, are two factors that will slow the growth of the dialysis access treatment devices market in the coming years. However, the rise in product recall issues may pose a significant obstacle to the dialysis access treatment devices market's growth in the near future.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Dialysis Access Treatment Devices Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Dialysis Access Treatment Devices Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

  • Nipro
  • Rockwell Medical
  • Nikkiso Co., Ltd.
  • Asahi Kasei Medical Co., Ltd.
  • GIA Medical
  • Kawasumi Laboratories. INC.
  • NxStage Medical, Inc.
  • AngioDynamics
  • Baxter
  • Texas Instruments Incorporated
  • DaVita Inc.
  • Diaverum
  • Teleflex Incorporated
  • CVS Health, Home Dialysis Central
  • Quanta Dialysis Technologies
  • Dialifegroup.com
  • JMS Co.Ltd.
  • Henry Schein, Inc.
  • Covestro AG
  • Fresenius Kabi AG

(Note: The list of the major players will be updated with the latest market scenario and trends)

By Treatment

  • Home Hemodialysis
  • Hemodialysis
  • Peritoneal Dialysis

By Types of Dialysis Membrane

  • Synthetic High-flux Membranes
  • Unmodified Cellulose Low-flux Membranes

By Renal Products

  • Blood Tubing Set and Accessories
  • Dialysis Machine
  • Hemofilter
  • Endotoxin Retention Filter
  • Dialyzer
  • Arterial Venous

By Disease Condition

  • Acute
  • Chronic

By Application

  • Serum and Blood Treatment
  • Virus Purification
  • Salt Removal
  • Drug Binding Studies
  • Buffer Exchange
  • Other Applications

By End-Users

  • Hospitals
  • Home Care Settings
  • Research Laboratories
  • Dialysis Centers
  • Clinics

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Dialysis Access Treatment Devices Market By Treatment, By Types of Dialysis Membrane, By Renal Products, By Disease Condition, By Application, By End-Users and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

 

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Dialysis Access Treatment Devices Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Dialysis Access Treatment Devices Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Dialysis Access Treatment Devices Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Dialysis Access Treatment Devices Market, By Treatment Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Home Hemodialysis
        2. Hemodialysis
        3. Peritoneal Dialysis

  • 8.   Dialysis Access Treatment Devices Market, By Types of Dialysis Membrane Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Synthetic High-flux Membranes
        2. Unmodified Cellulose Low-flux Membranes

  • 9.   Dialysis Access Treatment Devices Market, By Renal Products Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Blood Tubing Set and Accessories
        2. Dialysis Machine
        3. Hemofilter
        4. Endotoxin Retention Filter
        5. Dialyzer
        6. Arterial Venous

  • 10.   Dialysis Access Treatment Devices Market, By Disease Condition Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Acute
        2. Chronic

  • 11.   Dialysis Access Treatment Devices Market, By Application Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Serum and Blood Treatment
        2. Virus Purification
        3. Salt Removal
        4. Drug Binding Studies
        5. Buffer Exchange
        6. Other Applications

  • 12.   Dialysis Access Treatment Devices Market, By End-Users Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Hospitals
        2. Home Care Settings
        3. Research Laboratories
        4. Dialysis Centers
        5. Clinics

  • 13.   North America Dialysis Access Treatment Devices Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 14.   Latin America Dialysis Access Treatment Devices Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 15.   Europe Dialysis Access Treatment Devices Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 16.   Asia Pacific Dialysis Access Treatment Devices Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 17.   Middle East and Africa Dialysis Access Treatment Devices Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 18.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 19.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Nipro
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Rockwell Medical
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Nikkiso Co., Ltd.
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Asahi Kasei Medical Co., Ltd.
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. GIA Medical
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Kawasumi Laboratories. INC.
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. NxStage Medical, Inc.
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. AngioDynamics
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Baxter
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. Texas Instruments Incorporated
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
        11. DaVita Inc.
         11.1. Company Overview
         11.2. Product Portfolio
         11.3. SWOT Analysis
         11.4. Financial Overview
         11.5. Strategic Overview
        12. Diaverum
         12.1. Company Overview
         12.2. Product Portfolio
         12.3. SWOT Analysis
         12.4. Financial Overview
         12.5. Strategic Overview
        13. Teleflex Incorporated
         13.1. Company Overview
         13.2. Product Portfolio
         13.3. SWOT Analysis
         13.4. Financial Overview
         13.5. Strategic Overview
        14. CVS Health, Home Dialysis Central
         14.1. Company Overview
         14.2. Product Portfolio
         14.3. SWOT Analysis
         14.4. Financial Overview
         14.5. Strategic Overview
        15. Quanta Dialysis Technologies
         15.1. Company Overview
         15.2. Product Portfolio
         15.3. SWOT Analysis
         15.4. Financial Overview
         15.5. Strategic Overview
        16. Dialifegroup.com
         16.1. Company Overview
         16.2. Product Portfolio
         16.3. SWOT Analysis
         16.4. Financial Overview
         16.5. Strategic Overview
        17. JMS Co.Ltd.
         17.1. Company Overview
         17.2. Product Portfolio
         17.3. SWOT Analysis
         17.4. Financial Overview
         17.5. Strategic Overview
        18. Henry Schein, Inc.
         18.1. Company Overview
         18.2. Product Portfolio
         18.3. SWOT Analysis
         18.4. Financial Overview
         18.5. Strategic Overview
        19. Cove9tro AG
         19.1. Company Overview
         19.2. Product Portfolio
         19.3. SWOT Analysis
         19.4. Financial Overview
         19.5. Strategic Overview
        20. Fresenius Kabi AG
         20.1. Company Overview
         20.2. Product Portfolio
         20.3. SWOT Analysis
         20.4. Financial Overview
         20.5. Strategic Overview

  • 20.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations
  • 21.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients